Safety and Efficacy of ALRV5XR in Women with Androgenetic Alopecia or Telogen Effluvium: A Randomised, Double-Blinded, Placebo-Controlled Clinical Trial

    July 2021 in “ EClinicalMedicine
    Peter D. Feldman, Klaus M. Fiebig, Charles Piwko, Boris M. Mints, Dennis Brown, Deborah J. Cahan, Jaime Guevara-Aguirre

    We don't know much about this study yet.

    We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.
    Discuss this study in the Community →

    Cited in this study

    22 / 22 results

    Related

    5 / 5 results